scholarly journals Breast Ultrasound during Lactation: Benign and Malignant Lesions

Breast Care ◽  
2018 ◽  
Vol 14 (1) ◽  
pp. 30-34
Author(s):  
Nuray Haliloglu ◽  
Evren Ustuner ◽  
Esra Ozkavukcu
Keyword(s):  
Breast Cancer ◽  
Structural Changes ◽  
Imaging Findings ◽  
Breast Parenchyma ◽  
Lactating Women ◽  
Malignant Lesions ◽  
Us Findings ◽  
Us Scan ◽  
True Mass

Background: Structural changes during lactation make breast physical examination difficult. When breast problems occur, patients are often referred for an ultrasound (US) scan. Most breast lesions diagnosed in these patients are benign, but the diagnosis of breast cancer is a challenge. We aim to demonstrate the spectrum of US imaging findings in lactating women. Methods: 77 breastfeeding patients who underwent breast US in our department between February 2012 and March 2017 were evaluated. Patients' electronic medical records were reviewed for the presenting complaint, US reports, pathology results if available, and clinical/radiologic follow-up. All examinations were performed by 2 radiologists. Results: 28 of the 77 patients had normal US findings. Cysts were seen in 16 patients. 4 patients had stable fibroadenomas. 6 patients had US imaging findings suggestive of mastitis, 5 patients had galactoceles, 1 patient had an abscess, and 1 patient had unilateral hypertrophy without any accompanying lesion. In 13 patients, BI-RADS 3 solid masses were diagnosed. Invasive breast cancer was diagnosed in 3 patients. Conclusion: US can demonstrate or exclude a true mass against the background of a nodular breast parenchyma. Radiologists must be aware of malignant US features to avoid delays in the diagnosis of pregnancy-associated breast cancer.

scholarly journals Pregnancy-lactation cycle: how to use imaging methods for breast evaluation

2020 ◽  
Vol 53 (6) ◽  
pp. 405-412
Author(s):  
Carlos Henrique de Sousa Rosas ◽  
Ana Carolina de Ataíde Góes ◽  
Laís Martinho Saltão ◽  
Adriana Michiko da Silva Tanaka ◽  
Elvira Ferreira Marques ◽  
...  
Keyword(s):  
Breast Imaging ◽  
Structural Changes ◽  
Breast Diseases ◽  
Resonance Imaging ◽  
Breast Parenchyma ◽  
Imaging Methods ◽  
Pregnancy And Lactation ◽  
Malignant Lesions ◽  
Lactation Cycle ◽  
Puerperal Mastitis

Abstract Pregnancy and lactation constitute states of intense hormonal variation with secretory and structural changes in the breast parenchyma. These changes translate into important features on breast imaging, as well as the emergence of specific benign and malignant lesions. This literature review aims to discuss the safety of the use of breast imaging methods (mammography, ultrasound, and magnetic resonance imaging) during the pregnancy-lactation cycle, and to present the expected physiological changes and imaging appearance of the main breast diseases that may occur in this period, such as galactocele, lactating adenoma, fibroadenoma, puerperal mastitis, and pregnancy-associated breast cancer.

scholarly journals Contrast-enhanced spectral mammography: successful initial clinical institute experience

2021 ◽  
Vol 52 (1) ◽  
Author(s):  
Nivine Abdel Moneim Chalabi ◽  
Amal Amin AbuElMaati ◽  
Momena Essam Ibrahim Elsadawy
Keyword(s):  
Dense Breast ◽  
Breast Parenchyma ◽  
Contrast Enhanced ◽  
Egyptian Patients ◽  
Risk Patients ◽  
Proper Diagnosis ◽  
Malignant Lesions ◽  
Sensitivity Specificity

Abstract Background Contrast-enhanced spectral mammography (CESM) is a relatively newly developed advanced application with modification of digital mammography by the use of a contrast agent, but still has little known efficacy among Egyptian patients. Our aim in this study is to share our initial experience in evaluating symptomatic patients with different ACR breast parenchyma especially in dense breast parenchyma as it is always challenging in diagnosis. Results CESM in this study gave a sensitivity of 92% and specificity of 85% in characterization of benign and malignant lesions. For postoperative cases, sensitivity was 85% and specificity was 60%. For chemotherapy cases, sensitivity was 85% and specificity was 76%. Contrast uptake was noted in 68% of masses. Cavitary benign lesions were noted in 22.1% of cases. Multifocal and multicentric carcinomas were detected in 39.7% of pathologically proved malignant masses. Statistical analysis revealed sensitivity, specificity, and accuracy of 82.9%, 76.5%, and 81.0% for conventional mammograms as compared to 92.7%, 82.4%, and 89.7% for CESM respectively. Conclusion CESM is a promising technique that can enhance the specificity of conventional mammograms. It is an easy, simple, and rapid contrast-based procedure, especially for characterization of lesions in dense breast parenchyma. It performs proper diagnosis for high-risk patients and follow-up response to different lines of management.

scholarly journals Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment Modulation of Breast Cancer

2021 ◽  
Vol 11 (2) ◽  
pp. 81
Author(s):  
Ioana Boca (Bene) ◽  
Sorin M. Dudea ◽  
Anca I. Ciurea
Keyword(s):  
Breast Cancer ◽  
High Performance ◽  
Axillary Staging ◽  
Imaging Method ◽  
Contrast Enhanced Ultrasound ◽  
Contrast Enhanced ◽  
Contrast Enhanced Ultrasonography ◽  
Malignant Lesions

The aim of this paper is to highlight the role of contrast-enhanced ultrasound in breast cancer in terms of diagnosis, staging and follow-up of the post-treatment response. Contrast-enhanced ultrasound (CEUS) is successfully used to diagnose multiple pathologies and has also clinical relevance in breast cancer. CEUS has high accuracy in differentiating benign from malignant lesions by analyzing the enhancement characteristics and calculating the time-intensity curve’s quantitative parameters. It also has a significant role in axillary staging, especially when the lymph nodes are not suspicious on clinical examination and have a normal appearance on gray-scale ultrasound. The most significant clinical impact consists of predicting the response to neoadjuvant chemotherapy, which offers the possibility of adjusting the therapy by dynamically evaluating the patient. CEUS is a high-performance, feasible, non-irradiating, accessible, easy-to-implement imaging method and has proven to be a valuable addition to breast ultrasound.

Sign in / Sign up

Export Citation Format

Share Document